Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic dexamethasone for post–transarterial chemoembolization syndrome
KCT0002277Phase 4Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in hepatocellular carcinoma (HCC), sponsored by Seoul St. Mary's Hospital. Started Aug 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0002277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002277.